These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1817160)

  • 21. Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.
    Sallés J; Badia A
    Br J Pharmacol; 1993 Mar; 108(3):678-83. PubMed ID: 8096783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carrier-mediated outward transport of dopamine from adrenergic varicosities of the vas deferens of reserpine-pretreated rats.
    Langeloh A; Halbrügge T; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):619-22. PubMed ID: 1775194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intravenous vinblastine on intraneuronal transport of noradrenaline in the rat.
    Keen P; Livingston A
    Acta Physiol Scand Suppl; 1970; 357():13. PubMed ID: 5534108
    [No Abstract]   [Full Text] [Related]  

  • 24. The relation between in vitro efflux of noradrenaline from platelets and vas deferens in man.
    Mattiasson I; Nyström I; Abrahamsson PA; Hood B
    Acta Physiol Scand; 1985 Sep; 125(1):155-8. PubMed ID: 4050487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site(s) and ionic basis of alpha-autoinhibition and facilitation of "3H'noradrenaline secretion in guinea-pig vas deferens.
    Alberts P; Bartfai T; Stjärne L
    J Physiol; 1981 Mar; 312():297-334. PubMed ID: 6267264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of veratridine on the fluxes of 3H-noradrenaline and 3h-bretylium in the rat vas deferens in vitro.
    Ross SB; Kelder D
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 295(3):183-9. PubMed ID: 1012341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ageing on the number of neuronal noradrenaline uptake sites in the rat vas deferens.
    Markus RP; Werneck de Avellar MC
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):405-9. PubMed ID: 1436126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opposite modulation of cotransmitter release in guinea-pig vas deferens: increase of noradrenaline and decrease of ATP release by activation of prejunctional beta-adrenoceptors.
    Gonçalves J; Bültmann R; Driessen B
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):184-92. PubMed ID: 8717159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A thin-layer chromatographic procedure for the assay of labelled noradrenaline and its metabolites in tissues and in incubation medium.
    Vohra MM; Jayasundar S
    J Pharm Pharmacol; 1976 Nov; 28(11):810-4. PubMed ID: 11288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the dihydropyridine Bay K 8644 on the release of [3H]-noradrenaline from the rat isolated vas deferens.
    Ceña V; García AG; Khoyi MA; Salaices M; Sanchez-García P
    Br J Pharmacol; 1985 Jul; 85(3):691-6. PubMed ID: 2411327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal efflux of noradrenaline induced by tris or lithium as substitutes for extracellular sodium.
    Bönisch H; Langeloh A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):13-6. PubMed ID: 3016559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropeptide Y inhibits 3[H]noradrenaline release in the rat vas deferens independently of cAMP levels.
    Bitran M; Torres G; Tapia W; Huidobro-Toro JP
    Neurochem Int; 1996 Mar; 28(3):309-17. PubMed ID: 8813249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of the density of adrenergic innervation on the extracellular steady-state concentration gradient for 3H-noradrenaline.
    Schömig E; Azevedo I; Moura D; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):541-3. PubMed ID: 1528271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation frequency-noradrenaline release relationships examined in alpha2A-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
    Scheibner J; Trendelenburg AU; Hein L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Oct; 364(4):321-8. PubMed ID: 11683519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat.
    Graham JD; Lewis MJ; Li DM
    Br J Pharmacol; 1974 Oct; 52(2):233-6. PubMed ID: 4451818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.
    Azevedo I; Moura D; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):245-8. PubMed ID: 2234107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A maximum contraction and substantial quantities of tritium can be obtained from tetraethylammonium-treated [3H]-noradrenaline preloaded, rat vas deferens in response to a single electrical shock.
    Wakade AR
    Br J Pharmacol; 1980 Mar; 68(3):425-36. PubMed ID: 7052336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.
    Hovevey-Sion D; Finberg JP
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):70-6. PubMed ID: 3114651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model.
    Schömig E; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):631-40. PubMed ID: 3444480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
    Trendelenburg AU; Klebroff W; Hein L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):117-30. PubMed ID: 11534851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.